31 May Predictive Value of the Anti-Angiogenic Factors in Women with Chronic Kidney Disease
There is a need for better diagnostic tools to distinguish between the signs that mark the appearance of the pregnancy complication preeclampsia and the worsening of existing chronic kidney disease. To address this need, blood samples from 150 women with chronic kidney disease are collected on three separate occasions. The samples are analyzed using the Health Canada approved test for preeclampsia called the Elecsys PIGF and sFlt-1 immunoassay. The aim of this study is to try to help clinicians better predict the development of preeclampsia in women with chronic kidney disease and avoid unnecessary premature deliveries or delays in treatment.
Contact for this study:
Isabel Arruda, firstname.lastname@example.org